메뉴 건너뛰기




Volumn 45, Issue 3, 2004, Pages 450-454

Accurate dose calibrator activity measurement of 90Y-ibritumomab tiuxetan

Author keywords

90Y measurement; Dose calibrator; Ibritumomab tiuxetan

Indexed keywords

IBRITUMOMAB TIUXETAN; RADIOPHARMACEUTICAL AGENT; MONOCLONAL ANTIBODY;

EID: 2342655736     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (17)

References (8)
  • 1
    • 35448961113 scopus 로고    scopus 로고
    • Zevalin® (Ibritumomab Tiuxetan). San Diego, CA: IDEC Pharmaceuticals Corp.; January 2002:1-5.
    • Zevalin® (Ibritumomab Tiuxetan). San Diego, CA: IDEC Pharmaceuticals Corp.; January 2002:1-5.
  • 2
    • 34547673849 scopus 로고    scopus 로고
    • Part 35: Medical use of byproduct material
    • Nuclear Regulatory Commission
    • Nuclear Regulatory Commission. Part 35: medical use of byproduct material. Fed Reg. 2002;67:20370-20397.
    • (2002) Fed Reg , vol.67 , pp. 20370-20397
  • 3
    • 0002905521 scopus 로고
    • The enhanced triple to double coincidence ratio (ETDCR) method for standardization of radionuclides by liquid scintillation counting
    • Broda R, Pochwalski K. The enhanced triple to double coincidence ratio (ETDCR) method for standardization of radionuclides by liquid scintillation counting. Nucl Instrum Methods Phys Res. 1992;A312:85-89.
    • (1992) Nucl Instrum Methods Phys Res , vol.A312 , pp. 85-89
    • Broda, R.1    Pochwalski, K.2
  • 5
    • 1342308195 scopus 로고    scopus 로고
    • Experimental determination of calibration settings for plastic syringes containing solutions of Y-90 using commercial radionuclide calibrators
    • In press
    • Zimmerman BE, Cessna JT, Millican MA. Experimental determination of calibration settings for plastic syringes containing solutions of Y-90 using commercial radionuclide calibrators. Appl Radiat Isot. 2004. In press.
    • (2004) Appl Radiat Isot
    • Zimmerman, B.E.1    Cessna, J.T.2    Millican, M.A.3
  • 7
    • 35448964194 scopus 로고    scopus 로고
    • NUREG-1556
    • Nuclear Regulatory Commission, Program-Specific Guidance About Commercial Radiopharmacy Licenses. Washington, DC: U.S. Nuclear Regulatory Commission;
    • Nuclear Regulatory Commission. NUREG-1556, Volume 13: Consolidated Guidance About Materials Licenses - Program-Specific Guidance About Commercial Radiopharmacy Licenses. Washington, DC: U.S. Nuclear Regulatory Commission; 1999.
    • (1999) Consolidated Guidance About Materials Licenses , vol.13


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.